Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy

MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy

Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy

Treatment of acetaminophen-induced liver failure by blocking the death checkpoint protein TRAIL